C07C 327/38
Amides of thiocarboxylic acids
C07C327/38 (Amides of thiocarboxylic acids) appears on 347 US grants and 272 published applications in this corpus.
Search patents in C07C- Granted patents
- 347
- Published applications
- 272
- Assignees
- 200
- Inventors
- 866
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 9 | 0 |
| 1994 | 15 | 0 |
| 1995 | 11 | 0 |
| 1996 | 13 | 0 |
| 1997 | 16 | 0 |
| 1998 | 17 | 0 |
| 1999 | 15 | 0 |
| 2000 | 10 | 0 |
| 2001 | 19 | 6 |
| 2002 | 13 | 14 |
| 2003 | 13 | 17 |
| 2004 | 10 | 18 |
| 2005 | 4 | 9 |
| 2006 | 10 | 11 |
| 2007 | 4 | 14 |
| 2008 | 7 | 9 |
| 2009 | 7 | 9 |
| 2010 | 13 | 12 |
| 2011 | 8 | 13 |
| 2012 | 9 | 19 |
| 2013 | 10 | 13 |
| 2014 | 15 | 22 |
| 2015 | 22 | 17 |
| 2016 | 13 | 15 |
| 2017 | 15 | 15 |
| 2018 | 5 | 5 |
| 2019 | 8 | 3 |
| 2020 | 0 | 3 |
| 2021 | 3 | 3 |
| 2022 | 4 | 6 |
| 2023 | 2 | 3 |
| 2024 | 1 | 10 |
| 2025 | 1 | 6 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 327/40Having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to159
- C07C 327/48Having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered150
- C07C 327/56Having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom47
- C07C 327/46Having carbon atoms of thiocarboxamide groups bound to carbon atoms of rings31
- C07C 327/50Compounds containing any of the groups [image cpc-sch-c07c-0979.gif], x being a hetero7
Recent patents
- EP2 antagonist19 May 2026US 12,630,510 B2Ono Pharmaceutical Co., Ltd.
- Compounds and methods for the treatment of parasitic infections26 Aug 2025US 12,396,969 B2The Board of Trustees of the University of Illinois
- Functionally modified polypeptides and radiobiosynthesis26 Mar 2024US 11,939,617 B2Ikaria, Inc.
- Amide derivatives, process for preparation thereof and use thereof as insecticide19 Sep 2023US 11,760,742 B2Mitsui Chemicals, Inc.
- Broad spectrum antivirulence, anti-persistence compounds22 Aug 2023US 11,731,946 B2Aptuit (Verona) SRL, An Evotec Company
- Compounds and methods for the treatment of parasitic infections25 Dec 2025US 2025/0387359 A1The Board of Trustees of the University of Illinois
- Formation of amidines4 Dec 2025US 2025/0368679 A1
- Aryl cyclohexanedione derivative or salt thereof, pest control agent containing same, and method for use thereof17 Apr 2025US 2025/0122147 A1Adeka Corporation
- Arylcyclohexanedione derivative or salt thereof, pest control agent containing said compound, and method for using same6 Mar 2025US 2025/0072422 A1Adeka Corporation
- Dp antagonist6 Feb 2025US 2025/0042870 A1Ono Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Method of identifying negative hormone and/or antagonist activities151US 5,776,699 AAllergan, Inc. · 1998
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998
- Insecticidal N'-substituted-N,N'-disubstitutedhydrazines107US 6,013,836 ARohm and Haas Company · 2000
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998